anti-Coagulation Factor XIII, A1 Polypeptide (F13A1) Antibodies

F13A1 encodes the coagulation factor XIII A subunit. Additionally we are shipping Coagulation Factor XIII, A1 Polypeptide Kits (38) and Coagulation Factor XIII, A1 Polypeptide Proteins (12) and many more products for this protein.

list all antibodies Gene Name GeneID UniProt
F13A1 60327 O08619
F13A1 2162 P00488
F13A1 74145 Q8BH61
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Coagulation Factor XIII, A1 Polypeptide Antibodies at antibodies-online.com

Showing 10 out of 337 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Supplier Delivery Price Details
Human Rabbit Un-conjugated WB Western blot analysis of Factor XIII A expression in HeLa (A), A549 (B), rat heart (C) whole cell lysates. 200 μL Log in to see 13 to 14 Days
$487.50
Details
Human Goat Un-conjugated ELISA, WB ABIN238563 (0.1µg/ml) staining of Human Placenta lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 100 μg Log in to see 6 to 7 Days
$326.89
Details
Human Mouse Un-conjugated ELISA Detection limit for recombinant GST tagged F13A1 is approximately 0.3 ng/mL as a capture antibody. 0.1 mg Log in to see 8 to 11 Days
$450.00
Details
Mouse Rabbit Un-conjugated ICC, IHC, IP, WB 100 μg Log in to see 15 to 18 Days
$342.00
Details
Human Goat Un-conjugated WB   0.1 mg Log in to see 12 to 15 Days
$375.38
Details
Human Sheep Un-conjugated EIA, ID   1 mL Log in to see 6 to 8 Days
$401.50
Details
Human Goat Un-conjugated ELISA, WB Western Blot: Factor XIIIa Antibody [ABIN4086585] - (0.1ug/ml) staining of Human Placenta lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. 0.1 mg Log in to see 7 to 9 Days
$408.19
Details
Human Rabbit Un-conjugated IHC (p) 7 mL Log in to see 2 to 3 Days
$374.00
Details
Human Goat Un-conjugated EIA, IHC (p) F13A1 / Factor XIIIawas used in IHC to stain formalin-fixed, paraffin-embedded human skin, dermal inflammatory cells, followed by biotinylated horse anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen. Human Placenta (formalin-fixed, paraffin-embedded) stained with F13A1followed by biotinylated secondary antibody, alkaline phosphatase-streptavidin and chromogen. 50 μg Log in to see 6 to 8 Days
$500.50
Details
Human Rabbit Un-conjugated ICC, IF, IHC (p), WB WB Image Sample (30 ug of whole cell lysate) A:H1299 7.5 % SDS PAGE antibody diluted at 1:1000 IHC-P Image Factor XIIIa antibody [N1N3] detects Factor XIIIa protein at cytoplasm in mouse liver by immunohistochemical analysis. Sample: Paraffin-embedded mouse liver. Factor XIIIa antibody [N1N3] , diluted at 1:500. 100 μL Log in to see 1 to 2 Days
$358.60
Details

F13A1 Antibodies by Reactivity, Application, Clonality and Conjugate

Attributes Applications Host Clonality Conjugate
Rat (Rattus) ,


Human , , , ,
, , ,
,
, , , , , , , , , , , , , , , , , , ,
Mouse (Murine) ,
,


Top referenced anti-Coagulation Factor XIII, A1 Polypeptide Antibodies

  1. Human Polyclonal F13A1 Primary Antibody for ELISA, WB - ABIN408658 : Higaki, Nakano, Onaka, Amano, Tanioka, Harada, Hashimoto, Sakaida, Okita: Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn's disease. in Journal of gastroenterology and hepatology 2006 (PubMed)

  2. Human Polyclonal F13A1 Primary Antibody for ID, ELISA - ABIN2473585 : Wang, Yang, Ran: Localized papular mucinosis with IgA nephropathy: a case report. in Archives of dermatology 2011 (PubMed)

  3. Human Monoclonal F13A1 Primary Antibody for FACS, IF - ABIN5577652 : Davie, Fujikawa, Kisiel: The coagulation cascade: initiation, maintenance, and regulation. in Biochemistry 1991 (PubMed)

More Antibodies against Coagulation Factor XIII, A1 Polypeptide Interaction Partners

Cow (Bovine) Coagulation Factor XIII, A1 Polypeptide (F13A1) interaction partners

  1. kinetic and structural analysis of interactions between thrombin (show F2 Antibodies) and the Factor XIII (show UGDH Antibodies) activation peptide

Human Coagulation Factor XIII, A1 Polypeptide (F13A1) interaction partners

  1. These findings provide insight into assembly of the fibrinogen/FXIII-A2B2 complex in both physiologic and therapeutic situations.

  2. FXIIIa exhibits a preference for Q237 in crosslinking reactions within fibrinogen alphaC (233-425) followed by Q328 and Q366.

  3. factor XIII (show UGDH Antibodies) Val34Leu polymorphism is associated with coronary artery diseases risk, especially myocardial infarction. Age and sex did not affect the relationship between factor XIII (show UGDH Antibodies) Val34Leu polymorphism and diseases risk (Meta-Analysis)

  4. Genetic basis of severe factor XIII (show UGDH Antibodies) deficiency in a large cohort of Indian patients has been uncovered.

  5. Mutations in the activation peptide of full-length recombinant FXIII regulate activation rates by thrombin (show F2 Antibodies), and V34L influences in vivo thrombus formation by increased cross-linking of the clot (show TXNDC17 Antibodies).

  6. Report immunochromatographic test for detection of anti-factor XIII (show UGDH Antibodies) A subunit antibodies that can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII (show UGDH Antibodies).

  7. there is an evidence for association between factor XIII (show UGDH Antibodies) Val34Leu polymorphism and CSX (show NKX2-5 Antibodies)

  8. These findings expose a newly recognized, essential role for fibrin crosslinking during whole blood clot (show TXNDC17 Antibodies) formation and consolidation and establish FXIIIa activity as a key determinant of thrombus composition and size.

  9. Results show that FXIII-B Arg95 variant is associated with an increased risk of abdominal aortic aneurysms (AAA (show APP Antibodies)) suggesting a possible role for FXIII in AAA (show APP Antibodies) pathogenesis.

Mouse (Murine) Coagulation Factor XIII, A1 Polypeptide (F13A1) interaction partners

  1. These findings provide insight into assembly of the fibrinogen/FXIII-A2B2 complex in both physiologic and therapeutic situations.

  2. Mast cells have the ability to produce and degrade FXIIIA depending on their chymase (show CMA1 Antibodies) expression profile: mast cells expressing chymase (show CMA1 Antibodies) degrade FXIIIA, whereas mast cells that do not express chymase (show CMA1 Antibodies) mainly produce FXIIIA

  3. A lack of factor XIII (show UGDH Antibodies) leads to prolonged clotting times, increased signs of inflammation, and elevated bacterial dissemination in streptococcal skin diseases.

  4. These findings expose a newly recognized, essential role for fibrin crosslinking during whole blood clot (show TXNDC17 Antibodies) formation and consolidation and establish FXIIIa activity as a key determinant of thrombus composition and size.

  5. 5-HT (show DDC Antibodies) inhibits Factor XIII (show UGDH Antibodies)-A-mediated plasma fibronectin (show FN1 Antibodies) matrix assembly and crosslinking in osteoblast cultures via direct competition with transamidation

  6. High Transglutaminase factor XIII (show UGDH Antibodies) promotes arthritis through mechanisms linked to inflammation and bone erosion.

  7. Fibrinogen from mice harboring the Fibgamma390-396A mutation exhibited reduced binding to FXIII, and plasma from these mice exhibited delayed FXIII activation and fibrin crosslinking, indicating these residues mediate FXIII binding and activation.

  8. FXIII-A serves as a preadipocyte-bound proliferation/differentiation switch that mediates effects of hepatocyte-produced circulating pFN.

  9. Physiological significance of mouse TG2 (show TGM2 Antibodies) and Factor XIII (show UGDH Antibodies) through identification of substrate proteins in MC3T3-E1 cells.

  10. Studies indicate that in FXIII-A-knockout mice, tail-tip bleeding times are doubled and clot (show TXNDC17 Antibodies) stability, assessed by thromboelastography, was impaired compared with wild-type mice.

Coagulation Factor XIII, A1 Polypeptide (F13A1) Antigen Profile

Protein Summary

This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits\; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.

Gene names and symbols associated with F13A1

  • coagulation factor XIII A1 chain (F13a1) antibody
  • coagulation factor XIII, A1 polypeptide b (f13a1b) antibody
  • coagulation factor XIII A chain (F13A1) antibody
  • coagulation factor XIII, A1 subunit (F13a1) antibody
  • coagulation factor XIII A chain (F13a1) antibody
  • 1200014I03Rik antibody
  • AI462306 antibody
  • F13A antibody
  • F13A1 antibody
  • wu:fo83d04 antibody
  • zgc:153334 antibody

Protein level used designations for F13A1

coagulation factor XIII A chain , coagulation factor XIII, A1 subunit , coagulation factor XIIIa , protein-glutamine gamma-glutamyltransferase A chain , transglutaminase A chain , FX111a-87 , fo83d04 , coagulation factor XIII A1 subunit , coagulation factor XIII, A1 polypeptide , blood coagulation factor XIII A1 subunit , coagulation factor XIIIA , Coagulation factor XIII A chain , FSF, A subunit , TGase , bA525O21.1 (coagulation factor XIII, A1 polypeptide) , coagulation factor XIII, A polypeptide , factor XIIIa , fibrin stabilizing factor, A subunit , fibrinoligase , transglutaminase. plasma , Factor XIIIA , coagulation factor XIII, alpha subunit , coagulation factor XIII A chain-like

GENE ID SPECIES
60327 Rattus norvegicus
561287 Danio rerio
478711 Canis lupus familiaris
462413 Pan troglodytes
100060428 Equus caballus
617881 Bos taurus
395420 Gallus gallus
711264 Macaca mulatta
2162 Homo sapiens
74145 Mus musculus
100020636 Monodelphis domestica
100401849 Callithrix jacchus
100479900 Ailuropoda melanoleuca
100539806 Meleagris gallopavo
100581513 Nomascus leucogenys
100153504 Sus scrofa
100719684 Cavia porcellus
101108612 Ovis aries
101671512 Mustela putorius furo
Selected quality suppliers for anti-Coagulation Factor XIII, A1 Polypeptide (F13A1) Antibodies
Did you look for something else?